Patent: 4,820,731
✉ Email this page to a colleague
Summary for Patent: 4,820,731
| Title: | Parenteral dietary supplement and method of minimizing effects of infection through diet |
| Abstract: | Disclosed is a method of minimizing infection and minimizing the risks of infection in at risk animals and patients. A dietary supplement to accomplish this objective is also disclosed. The method includes the step of administering a diet rich in .omega.3 fatty acids, for example by adding a substantial proportion of fish oils to the diet. The dietary supplement is particularly well suited to patients receiving total parenteral nutrition. A parenteral diet or diet supplement containing a mixture of oils, one rich in .omega.3 fatty acids and the other rich in .omega.6 fatty acids is disclosed. |
| Inventor(s): | Mascioli; Edward A. (Cambridge, MA), Blackburn; George L. (Jamaica Plain, MA), Bistrian; Bruce R. (Ipswitch, MA), Babayan; Vigen K. (Waban, MA) |
| Assignee: | New England Deaconess Hospital Corporation (Boston, MA) |
| Application Number: | 07/207,122 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,820,731
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2039-09-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
